Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(R)-HH2853, an EZH2 inhibitor variant, demonstrates potent inhibitory action with an IC50 of less than 100 nM specifically targeting the EZH2-Y641F mutation. This compound holds potential therapeutic applications in treating cancer and autoimmune diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 333.00 |
Description | (R)-HH2853, an EZH2 inhibitor variant, demonstrates potent inhibitory action with an IC50 of less than 100 nM specifically targeting the EZH2-Y641F mutation. This compound holds potential therapeutic applications in treating cancer and autoimmune diseases. |
Molecular Weight | 611.66 |
Formula | C31H36F3N7O3 |
CAS No. | 2202678-06-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(R)-HH2853 2202678-06-4 inhibitor inhibit